← Back to headlines
TD Cowen Lifts Price Target on Regeneron Pharmaceuticals Ahead of Q1 Results
TD Cowen has increased its price target for Regeneron Pharmaceuticals, signaling optimism for the company's financial performance ahead of its fiscal first-quarter results.
27 Apr, 06:04 — 27 Apr, 06:04
Sources
Showing 1 of 1 sources



